
FDA Rejects MDMA for Mental Health Treatment After Identifying Flawed Study Data
CCHR welcomes the FDA’s decision to disapprove the hallucinogenic drug, MDMA (Ecstasy) saying if approved, it would have fueled a planned $12 billion industry to…


CCHR welcomes the FDA’s decision to disapprove the hallucinogenic drug, MDMA (Ecstasy) saying if approved, it would have fueled a planned $12 billion industry to…

Mental health industry watchdog says psychiatric restraints need to be banned in the U.S. and worldwide as part of ending coercive psychiatric practices. By CCHR…

$280 billion in mental health funding hasn’t ended violent restraint use and patient deaths. And in schools, despite mental health screening and treatment, the culture…

Psychiatrists’ increasing reliance upon involuntary commitment in psychiatric facilities and forced mental health treatment has caused a litany of harm and human rights abuses—funded by…

In light of a recent media investigation and Medicare statistics, a mental health watchdog says increased government oversight of antipsychotic use and electroshocking of nursing…